- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/00 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patent holdings for IPC class C07D 277/00
Total number of patents in this class: 88
10-year publication summary
|
7
|
2
|
2
|
2
|
3
|
1
|
2
|
2
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Case Western Reserve University | 1899 |
5 |
| Amgen Inc. | 4440 |
3 |
| Vertex Pharmaceuticals Incorporated | 1579 |
3 |
| Allergan, Inc. | 2157 |
2 |
| Bayer Cropscience AG | 1836 |
2 |
| The Trustees of the University of Pennsylvania | 4423 |
2 |
| CARA Therapeutics, Inc. | 37 |
2 |
| FerroKin Biosciences, Inc. | 5 |
2 |
| Synapse Biosciences, LLC | 3 |
2 |
| Compagnie Generale des Etablissements Michelin | 4975 |
2 |
| Corteva Agriscience LLC | 2644 |
2 |
| F. Hoffmann-La Roche AG | 7808 |
1 |
| Sandoz AG | 1410 |
1 |
| The Regents of the University of California | 20815 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| E. I. du Pont de Nemours and Company | 3486 |
1 |
| Bayer AG | 3522 |
1 |
| Sumitomo Chemical Company, Limited | 8968 |
1 |
| The Johns Hopkins University | 5913 |
1 |
| Abbvie Inc. | 1799 |
1 |
| Other owners | 52 |